Potential health hazard — use of or exposure to this product may cause temporary or medically reversible adverse health consequences.
Levothyroxine Sodium 135 mcg/Liothyronine 15 mcg SR capsules Recalled by MOORE'S COMPOUNDING PHARMACY Due to Superpotent Drug and Subpotent Drug; potency failures obtained
What You Should Do
Stop using this product immediately. Do not consume, use, or distribute it.
Return the product to the place of purchase for a full refund. If you have questions, contact MOORE'S COMPOUNDING PHARMACY directly.
Affected Products
Levothyroxine Sodium 135 mcg/Liothyronine 15 mcg SR capsules, 90 count bottles, Rx only, Moore's Pharmacy Compounding, Corpus Christi, TX
Quantity: 90 capsules
Why Was This Recalled?
Superpotent Drug and Subpotent Drug; potency failures obtained
Where Was This Sold?
This product was distributed to 1 state: TX
About MOORE'S COMPOUNDING PHARMACY
MOORE'S COMPOUNDING PHARMACY has 1 total recall tracked by RecallDetector.
Related Recalls
Icosapent Ethyl Capsules Recalled by Zydus Pharmaceuticals (USA) Inc Due to Failed Tablet/Capsule specifications: Red dots inside capsule and...
Zydus Pharmaceuticals (USA) Inc · March 9, 2026
Product label: Temozolomide Capsules Recalled by Rising Pharma Holding, Inc. Due to Failed Impurities/Degradation Specifications: An out-of-specification result observed during...
Rising Pharma Holding, Inc. · March 3, 2026
Semaglutide Inj. Recalled by New Life Pharma LLC Due to Lack of Assurance of Sterility
New Life Pharma LLC · February 26, 2026
Tirzepatide Inj Recalled by New Life Pharma LLC Due to Lack of Assurance of Sterility
New Life Pharma LLC · February 26, 2026
Tirzepatide Inj Recalled by New Life Pharma LLC Due to Lack of Assurance of Sterility
New Life Pharma LLC · February 26, 2026
Data sourced from the FDA (Drug). Last updated March 26, 2026. View original report